GB0027309D0 - Method of measuring measuring platlet activation - Google Patents

Method of measuring measuring platlet activation

Info

Publication number
GB0027309D0
GB0027309D0 GBGB0027309.4A GB0027309A GB0027309D0 GB 0027309 D0 GB0027309 D0 GB 0027309D0 GB 0027309 A GB0027309 A GB 0027309A GB 0027309 D0 GB0027309 D0 GB 0027309D0
Authority
GB
United Kingdom
Prior art keywords
measuring
activation
platelet
platlet
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0027309.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Barts and London NHS Trust
Original Assignee
Barts and London NHS Trust
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Barts and London NHS Trust filed Critical Barts and London NHS Trust
Priority to GBGB0027309.4A priority Critical patent/GB0027309D0/en
Publication of GB0027309D0 publication Critical patent/GB0027309D0/en
Priority to AU2002212529A priority patent/AU2002212529B2/en
Priority to EP01980741A priority patent/EP1332373B1/en
Priority to ES01980741T priority patent/ES2372810T3/es
Priority to CA2428224A priority patent/CA2428224C/en
Priority to AU1252902A priority patent/AU1252902A/xx
Priority to US10/415,336 priority patent/US7011938B2/en
Priority to AT01980741T priority patent/ATE522808T1/de
Priority to JP2002541398A priority patent/JP2004513369A/ja
Priority to PCT/GB2001/004946 priority patent/WO2002039124A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2525—Stabilizing or preserving

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Ecology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0027309.4A 2000-11-08 2000-11-08 Method of measuring measuring platlet activation Ceased GB0027309D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB0027309.4A GB0027309D0 (en) 2000-11-08 2000-11-08 Method of measuring measuring platlet activation
PCT/GB2001/004946 WO2002039124A1 (en) 2000-11-08 2001-11-08 Method of measuring platelet activation
CA2428224A CA2428224C (en) 2000-11-08 2001-11-08 Method of measuring platelet activation
EP01980741A EP1332373B1 (en) 2000-11-08 2001-11-08 Method of measuring leucocyte activation
ES01980741T ES2372810T3 (es) 2000-11-08 2001-11-08 Método para medir la activación de leucocitos.
AU2002212529A AU2002212529B2 (en) 2000-11-08 2001-11-08 Method of measuring platelet activation
AU1252902A AU1252902A (en) 2000-11-08 2001-11-08 Method of measuring platelet activation
US10/415,336 US7011938B2 (en) 2000-11-08 2001-11-08 Method of measuring platelet activation
AT01980741T ATE522808T1 (de) 2000-11-08 2001-11-08 Verfahren zur bestimmung der aktivierung von leukozyten
JP2002541398A JP2004513369A (ja) 2000-11-08 2001-11-08 血小板活性の測定方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0027309.4A GB0027309D0 (en) 2000-11-08 2000-11-08 Method of measuring measuring platlet activation

Publications (1)

Publication Number Publication Date
GB0027309D0 true GB0027309D0 (en) 2000-12-27

Family

ID=9902807

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0027309.4A Ceased GB0027309D0 (en) 2000-11-08 2000-11-08 Method of measuring measuring platlet activation

Country Status (9)

Country Link
US (1) US7011938B2 (https=)
EP (1) EP1332373B1 (https=)
JP (1) JP2004513369A (https=)
AT (1) ATE522808T1 (https=)
AU (2) AU1252902A (https=)
CA (1) CA2428224C (https=)
ES (1) ES2372810T3 (https=)
GB (1) GB0027309D0 (https=)
WO (1) WO2002039124A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2392724A (en) * 2002-09-06 2004-03-10 Ian Stoakes Methods of and apparatus for blood analysis
WO2006014958A2 (en) * 2004-07-26 2006-02-09 Bayer Healthcare Llc Platelet activation markers as predictors of disease and of response to therapy and for monitoring therapeutic progress
US7811549B2 (en) 2006-07-05 2010-10-12 Adenobio N.V. Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects
US8021854B2 (en) * 2007-10-05 2011-09-20 Attila Mady Method of treating vascular disease
US8835104B2 (en) * 2007-12-20 2014-09-16 Fenwal, Inc. Medium and methods for the storage of platelets
WO2009092516A2 (en) * 2008-01-22 2009-07-30 Adenobio N.V. Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects
WO2011140241A2 (en) 2010-05-04 2011-11-10 The General Hospital Corporation Methods and compositions for preserving tissues and organs
US9402866B2 (en) 2011-04-07 2016-08-02 Fenwal, Inc. Automated methods and systems for providing platelet concentrates with reduced residual plasma volumes and storage media for such platelet concentrates
DK3054936T5 (da) 2013-10-10 2024-03-18 Eastern Virginia Medical School 4-((2-hydroxy-3-methoxybenzyl)amino) benzensulfonamid derivater som 12-lipoxygenase inhibitorer
EP3698628A1 (en) 2014-08-07 2020-08-26 The General Hospital Corporation Stabilization of whole blood samples
US20180015455A1 (en) 2016-07-12 2018-01-18 Emulate Inc. Additive channels

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08220094A (ja) * 1995-02-08 1996-08-30 Dai Ichi Pure Chem Co Ltd 血漿中ｇｍｐ−１４０の測定法
FR2731277A1 (fr) * 1995-03-02 1996-09-06 Benveniste Jacques Procedes et appareil pour faciliter la purification, le comptage et la mesure de l'activation des leucocytes sanguins
US5817519A (en) * 1995-12-28 1998-10-06 Bayer Corporation Automated method and device for identifying and quantifying platelets and for determining platelet activation state using whole blood samples
US6309888B1 (en) * 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease

Also Published As

Publication number Publication date
EP1332373B1 (en) 2011-08-31
JP2004513369A (ja) 2004-04-30
US20040038997A1 (en) 2004-02-26
AU2002212529B2 (en) 2006-08-10
ES2372810T3 (es) 2012-01-26
CA2428224C (en) 2010-04-27
CA2428224A1 (en) 2002-05-16
US7011938B2 (en) 2006-03-14
WO2002039124A1 (en) 2002-05-16
EP1332373A1 (en) 2003-08-06
AU1252902A (en) 2002-05-21
ATE522808T1 (de) 2011-09-15

Similar Documents

Publication Publication Date Title
GB0027309D0 (en) Method of measuring measuring platlet activation
EP1212613A4 (en) HEMATOLOGICAL CONTROL AND SYSTEM FOR HEMATOLOGIC MUCH PARAMETER MEASUREMENTS
FI905725L (fi) Reagenssi ja sitä käyttävä menetelmä vähintään yhden leukosyyttialapopulaation määrittämiseksi kokoverestä automaattisella virtaussolulaskennalla
FI915150A7 (fi) Menetelmät, reagenssit ja testikäyttöpakkaukset biologisten yksiköiden alapopulaatioiden määrittämiseksi
BR0014801A (pt) Sistemas de processamento de sangue que monitoram densidades óticas
WO2002090976A3 (en) Disposable cup and cone used in blood analysis instrumentation
DE69917051D1 (de) "flow-zytometrischer" vollblut- dendritzelle- immunfunctiontest
FI875609A7 (fi) Testikantaja kehon nesteiden ainesosasten analyyttistä määritystä varten.
DE69011198D1 (de) Verfahren zur Differenzierung von Leukozyten mit Hilfe eines Durchflusszellmessgerätes.
ATE337806T1 (de) Spritzenkit für die konzentration von thrombozyten und verfahren
BR9909897A (pt) Processo e sistema para o otimizar velocidade de penetração
DE68908685D1 (de) Verfahren zur verwendung chemilumineszierender 1,2-dioxetane.
BR9507690A (pt) Detecção de reticulócitos
DE69008753D1 (de) Verfahren zur Verbesserung der Messgenauigkeit bei der Abweichungsmessung.
DK285390D0 (da) Acridinorangederivater, sammensaetninger indeholdende disse og fremgangsmaade til kvantificering af reticulocytter i helblod
NL7805679A (nl) Werkwijze en inrichting voor het bepalen van het soor- telijk gewicht van een verzwaarde spoeling van een diep-, in het bijzonder een olieboring.
DE3851923D1 (de) Reagenz zur Retikulozytenzählung mittels Durchflusszytometrie.
EP0853761A4 (en) STANDARD FOR BLOOD CONTROL
BR9406223A (pt) Método para determinar em uma amostra a atividade funcional de um componente da coagulação sanguinea método para diagnosticar um disturbio da coagulação/anticoagulação sanguinea preparado de anticorpo linhagem celular uso de fator v subunidades ou fragmentos do mesmo tendo atividade anticoagulante na forma de cofator par apc prepraro de plasma embalado plasma deficiente em atividade anticoagulante de fator v como cofator para apc uso do preparado de anticorpo preparado de proteina s preparado de
DE3852439D1 (de) Reagenz zur Retikulozytenzählung mittels Durchfluss-zytometrie.
AU3259999A (en) Method of measuring erythrocyte sedimentation rate (esr) or plasma fibrinogen ofa blood sample
NO171282C (no) Fremgangsmaate for bestemmelse av mikrobekonsentrasjoner med en smelteagarmetode, samt deri anvendte skaaler
AU4462289A (en) Aqueous suspension for diagnostic tests
DE59914955D1 (de) Multiküvettenrotor
DE3681173D1 (de) Verfahren zur volumenmessung.

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)